Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Bonus plan approved Inv. presentation Acq. announced Director departure
|
CUBIST PHARMACEUTICALS INC (CBST)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/21/2015 |
4
| MOULDER LEON O JR (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
01/21/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/21/2015 |
4
| MARTIN KENNETH J (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed/sold 14,686 options to buy
@ $64.341, valued at
$944.9k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
01/21/2015 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 4,717 shares
@ $102, valued at
$481.1k
Disposed/sold 10,842 options to buy
@ $40.59, valued at
$440.1k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
01/21/2015 |
4
| HENNEY JANE E MD (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 4,644 shares
@ $102, valued at
$473.7k
Disposed/sold 10,176 options to buy
@ $42.64, valued at
$433.9k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
01/21/2015 |
4
| Hutson Nancy J (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 5,951 shares
@ $102, valued at
$607k
Disposed/sold 16,519 options to buy
@ $21.01, valued at
$347.1k
Disposed/sold 9,472 options to buy
@ $38.06, valued at
$360.5k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
01/21/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
01/21/2015 |
4
| BATE KENNETH (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
01/21/2015 |
4
| VINK PATRICK V.J.J. (EVP and COO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
01/21/2015 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 14,765 shares
@ $102, valued at
$1.5M
Disposed of 1,199 shares
@ $102, valued at
$122.3k
Disposed/sold 1,500 restricted stock units
@ $0 Disposed/sold 5,875 options to buy
@ $34.795, valued at
$204.4k
Disposed/sold 10,000 options to buy
@ $42.09, valued at
$420.9k
Disposed/sold 1,667 restricted stock units
@ $0 Disposed/sold 15,000 options to buy
@ $43.81, valued at
$657.2k
Disposed/sold 2,500 restricted stock units
@ $0 Disposed/sold 18,404 options to buy
@ $41.6, valued at
$765.6k
Disposed/sold 2,253 restricted stock units
@ $0 Disposed/sold 3,004 options to buy
@ $0 |
|
01/21/2015 |
4
| PEREZ ROBERT J (CEO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 47,325 shares
@ $102, valued at
$4.8M
Disposed of 5,012 shares
@ $102, valued at
$511.2k
Disposed/sold 25,000 options to buy
@ $23.12, valued at
$578k
Disposed/sold 50,000 options to buy
@ $21.91, valued at
$1.1M
Disposed/sold 40,000 options to buy
@ $18.1, valued at
$724k
Disposed/sold 62,500 options to buy
@ $16.76, valued at
$1M
Disposed/sold 75,000 options to buy
@ $21.56, valued at
$1.6M
Disposed/sold 5,000 restricted stock units
@ $0 Disposed/sold 100,000 options to buy
@ $34.795, valued at
$3.5M
Disposed/sold 100,000 options to buy
@ $42.09, valued at
$4.2M
Disposed/sold 10,000 restricted stock units
@ $0 |
|
01/21/2015 |
4
| GILMAN STEVEN C (EVP & Chief Scientific Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 27,680 shares
@ $102, valued at
$2.8M
Disposed of 2,851 shares
@ $102, valued at
$290.8k
Disposed/sold 1,000 options to buy
@ $16.76, valued at
$16.8k
Disposed/sold 60,000 options to buy
@ $21.56, valued at
$1.3M
Disposed/sold 9,375 options to buy
@ $25.23, valued at
$236.5k
Disposed/sold 3,500 restricted stock units
@ $0 Disposed/sold 21,875 options to buy
@ $34.795, valued at
$761.1k
Disposed/sold 75,000 options to buy
@ $42.09, valued at
$3.2M
Disposed/sold 7,500 restricted stock units
@ $0 Disposed/sold 47,851 options to buy
@ $41.6, valued at
$2M
Disposed/sold 5,859 restricted stock units
@ $0 |
|
01/21/2015 |
4
| DesRosier Thomas (EVP, Chief Legal) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 7,967 shares
@ $102, valued at
$812.6k
Disposed of 479 shares
@ $102, valued at
$48.9k
Disposed/sold 52,232 options to buy
@ $45.9, valued at
$2.4M
Disposed/sold 7,132 restricted stock units
@ $0 Disposed/sold 33,433 options to buy
@ $73.55, valued at
$2.5M
Disposed/sold 4,900 restricted stock units
@ $0 Disposed/sold 4,356 options to buy
@ $0 |
|
01/21/2015 |
4
| BONNEY MICHAEL W (CEO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 176,226 shares
@ $102, valued at
$18M
Disposed of 6,816 shares
@ $102, valued at
$695.2k
Disposed of 600 shares
@ $102, valued at
$61.2k
Disposed/sold 100,000 options to buy
@ $10.87, valued at
$1.1M
Disposed/sold 80,000 options to buy
@ $21.61, valued at
$1.7M
Disposed/sold 125,000 options to buy
@ $19.51, valued at
$2.4M
Disposed/sold 150,000 options to buy
@ $18.1, valued at
$2.7M
Disposed/sold 150,000 options to buy
@ $16.76, valued at
$2.5M
Disposed/sold 135,000 options to buy
@ $21.56, valued at
$2.9M
Disposed/sold 8,000 restricted stock units
@ $0 Disposed/sold 175,000 options to buy
@ $34.795, valued at
$6.1M
|
|
01/05/2015 |
4
| VINK PATRICK V.J.J. (EVP and COO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
01/05/2015 |
4
| PEREZ ROBERT J (CEO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 32 shares
@ $59.959, valued at
$1.9k
Granted 12,419 restricted stock units
@ $0 |
|
01/05/2015 |
4
| DesRosier Thomas (EVP, Chief Legal) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 148 shares
@ $59.959, valued at
$8.9k
|
|
01/05/2015 |
4
| GILMAN STEVEN C (EVP & Chief Scientific Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 82 shares
@ $59.959, valued at
$4.9k
|
|
12/31/2014 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 11,367 shares
@ $100.71, valued at
$1.1M
Exercised 20,000 options to buy
@ $23.5, valued at
$470k
|
|
12/31/2014 |
4
| DesRosier Thomas (EVP, Chief Legal Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 11,978 shares
@ $100.71, valued at
$1.2M
Exercised 17,975 options to buy
@ $45.9, valued at
$825.1k
|
|
10/16/2014 |
4
| VINK PATRICK V.J.J. (SVP & GM, International Bus.) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
10/02/2014 |
4
| GILMAN STEVEN C (EVP & Chief Scientific Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Exercised 48,125 shares
@ $65.3862, valued at
$3.1M
Sold 25,500 shares
@ $65.1121, valued at
$1.7M
Sold 22,225 shares
@ $65.6806, valued at
$1.5M
Sold 400 shares
@ $66.5, valued at
$26.6k
Exercised 48,125 options to buy
@ $34.795, valued at
$1.7M
|
|
10/02/2014 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 63 shares
@ $66.34, valued at
$4.2k
|
|
10/02/2014 |
4
| STEA GREGORY (SVP, Commercial Operations) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
10/02/2014 |
4
| DesRosier Thomas (EVP, Chief Legal) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 48 shares
@ $66.34, valued at
$3.2k
|
|
08/20/2014 |
4
| STEA GREGORY (SVP, Commercial Operations) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
08/18/2014 |
4
| Hutson Nancy J (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Exercised 9,000 shares
@ $0 Sold 9,000 shares
@ $65, valued at
$585k
Exercised 9,000 options to buy
@ $18.22, valued at
$164k
|
|
08/18/2014 |
4
| PEREZ ROBERT J (President & COO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Sold 1,003 shares
@ $63.6754, valued at
$63.9k
Exercised 2,125 restricted stock units
@ $0 |
|
08/18/2014 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Sold 409 shares
@ $63.6754, valued at
$26k
Exercised 1,250 restricted stock units
@ $0 |
|
07/29/2014 |
4
| GILMAN STEVEN C (EVP & Chief Scientific Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Sold 34,100 shares
@ $61.3982, valued at
$2.1M
Sold 6,525 shares
@ $62.4407, valued at
$407.4k
Exercised 34,100 options to buy
@ $25.23, valued at
$860.3k
Exercised 6,525 options to buy
@ $25.23, valued at
$164.6k
|
|
07/02/2014 |
4
| TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 82 shares
@ $69.82, valued at
$5.7k
|
|
07/02/2014 |
4
| STEA GREGORY (SVP, Commercial Operations) has filed a Form 4 on CUBIST PHARMACEUTICALS INC |
07/02/2014 |
4
| PEREZ ROBERT J (President & COO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 334 shares
@ $57.868, valued at
$19.3k
|
|
07/02/2014 |
4
| GILMAN STEVEN C (EVP & Chief Scientific Officer) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Acquired 107 shares
@ $69.82, valued at
$7.5k
|
|
|
|
|